Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

oligometastasis

  • Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
    You have access
    Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
    Milan Grkovski, Joseph A. O’Donoghue, Brandon S. Imber, George Andl, Cheng Tu, Daniel Lafontaine, Jazmin Schwartz, Maria Thor, Michael J. Zelefsky, John L. Humm and Lisa Bodei
    Journal of Nuclear Medicine November 1, 2023, 64 (11) 1779-1787; DOI: https://doi.org/10.2967/jnumed.123.265763
  • You have access
    Oligometastatic Prostate Cancer: Current Status and Future Challenges
    Hossein Jadvar, Andre Luis Abreu, Leslie K. Ballas and David I. Quinn
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1628-1635; DOI: https://doi.org/10.2967/jnumed.121.263124
  • You have access
    Intention-to-Treat Analysis of 68Ga-PSMA and 11C-Choline PET/CT Versus CT for Prostate Cancer Recurrence After Surgery
    Johannes Schwenck, Susann-Cathrin Olthof, Christina Pfannenberg, Gerald Reischl, Daniel Wegener, Jolanta Marzec, Jens Bedke, Arnulf Stenzl, Konstantin Nikolaou, Christian la Fougère, Daniel Zips and Arndt-Christian Müller
    Journal of Nuclear Medicine October 1, 2019, 60 (10) 1359-1365; DOI: https://doi.org/10.2967/jnumed.118.224543
SNMMI

© 2025 SNMMI

Powered by HighWire